
CASE Op-Ed in RealClearHealth: CMS Rule on Weight-Loss Drugs Would Reduce Healthcare Costs Along With Waistlines
As many well know, America has a persistent – and rising – epidemic of obesity. According to the Centers for...
As many well know, America has a persistent – and rising – epidemic of obesity. According to the Centers for...
(Alexandria, Virginia) – This morning Consumer Action for a Strong Economy (CASE) released the following statement today after the Food...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2025 · Case for Consumers